ES2042567T3 - Un procedimiento para la preparacion de un derivado de ergolina. - Google Patents

Un procedimiento para la preparacion de un derivado de ergolina.

Info

Publication number
ES2042567T3
ES2042567T3 ES87305570T ES87305570T ES2042567T3 ES 2042567 T3 ES2042567 T3 ES 2042567T3 ES 87305570 T ES87305570 T ES 87305570T ES 87305570 T ES87305570 T ES 87305570T ES 2042567 T3 ES2042567 T3 ES 2042567T3
Authority
ES
Spain
Prior art keywords
hydrogen atom
group
procedure
preparation
ergoline derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87305570T
Other languages
English (en)
Inventor
Aldemio Temperilli
Enzo Brambilla
Mauro Gobbini
Maria Antonietta Cervini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Farmitalia Carlo Erba SRL
Carlo Erba SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmitalia Carlo Erba SRL, Carlo Erba SpA filed Critical Farmitalia Carlo Erba SRL
Application granted granted Critical
Publication of ES2042567T3 publication Critical patent/ES2042567T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Liquid Developers In Electrophotography (AREA)
  • Graft Or Block Polymers (AREA)
  • Developing Agents For Electrophotography (AREA)

Abstract

DERIVADOS DE ERGOLINA DE FORMULA GENERAL (I) DONDE R1 REPRESENTA UN ATOMO DE HIDROGENO O UN GRUPO METOXI Y R2 REPRESENTA UN ATOMO DE HIDROGENO O R1 Y R2 TOMADOS CONJUNTAMENTE REPRESENTAN UN ENLACE QUIMICO Y R3 REPRESENTA UN ATOMO DE HIDROGENO, Y UN GRUPO NICOTINOILO SUSTITUIDO O NO SUSTITUIDO O UN GRUPO 1-OXO-2-CICLOPENTANO-3-IL; O UNA SAL ACEPTABLE FARMACEUTICAMENTE ES ACTIVA A NIVEL DEL SISTEMA NERVIOSO CENTRAL Y POR ESO ES UTIL HABITUALMENTE EN EL TRATAMIENTO DE LA INSUFICIENCIA CEREBRAL Y EN LA DEMENCIA SENIL.
ES87305570T 1986-06-25 1987-06-23 Un procedimiento para la preparacion de un derivado de ergolina. Expired - Lifetime ES2042567T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868615471A GB8615471D0 (en) 1986-06-25 1986-06-25 T-butyl ergoline derivatives

Publications (1)

Publication Number Publication Date
ES2042567T3 true ES2042567T3 (es) 1993-12-16

Family

ID=10600059

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87305570T Expired - Lifetime ES2042567T3 (es) 1986-06-25 1987-06-23 Un procedimiento para la preparacion de un derivado de ergolina.

Country Status (20)

Country Link
US (2) US4843073A (es)
EP (1) EP0251652B1 (es)
JP (1) JPH0745498B2 (es)
KR (1) KR950008970B1 (es)
AT (1) ATE76407T1 (es)
AU (1) AU597672B2 (es)
CA (1) CA1339533C (es)
DE (1) DE3779190D1 (es)
DK (1) DK170099B1 (es)
ES (1) ES2042567T3 (es)
FI (1) FI85702C (es)
GB (1) GB8615471D0 (es)
GR (1) GR3005115T3 (es)
HU (1) HU196201B (es)
IE (1) IE61319B1 (es)
IL (1) IL82946A (es)
NZ (1) NZ220543A (es)
PT (1) PT85152B (es)
SU (1) SU1547708A3 (es)
ZA (1) ZA874569B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61245164A (ja) * 1985-04-23 1986-10-31 Seiko Instr & Electronics Ltd パタ−ン修正装置
HU193782B (en) * 1985-06-21 1987-11-30 Richter Gedeon Vegyeszet Process for producing 2-halogeno-nicergoline derivatives and acid additional salts thereof
US6060483A (en) * 1996-06-27 2000-05-09 Pharmacia & Upjohn S.P.A. Antineurodegenerative ergoline derivatives
WO2014195849A2 (en) * 2013-06-03 2014-12-11 Mahesh Kandula Compositions and methods for the treatment of cerebrovascular diseases

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3228945A (en) * 1966-01-11 Methyl and i,g-dimethyl-b-(a-hydroxy- alkyl)-ergoline i derivatives
US3228941A (en) * 1966-01-11 Methyl and i,g-dimethyl-ergoline i derivatives
US3228942A (en) * 1966-01-11 Methyl and i,g-dimeti-iyl ergoline i compounds
DE203721C (es) * 1908-05-05
US3232942A (en) * 1964-06-02 1966-02-01 Sandoz Ltd 1-substituted (+)-lysergol
US3879554A (en) * 1970-03-20 1975-04-22 Farmaceutici Italia Use of 1,6-dimethyl-8-{62 -(5-bromonicotinoyloxymethyl)-10 {60 -methoxyergoline in treating cerebral and peripheral metabolic vascular disorders
USRE30218E (en) * 1974-12-06 1980-02-19 Eli Lilly And Company 8,8-Disubstituted-6-methylergolines and related compounds
US3959288A (en) * 1974-12-13 1976-05-25 Eli Lilly And Company 8-Oxymethylergolines and process therefor
US4199579A (en) * 1975-03-14 1980-04-22 Siphar S. A. Carbamates of 2-haloergolines and 2-haloergolenes and process for the preparation thereof
DE2656344A1 (de) * 1975-12-23 1977-07-07 Sandoz Ag Ergolinderivate, ihre verwendung und herstellung
IT1192260B (it) * 1977-07-05 1988-03-31 Simes Derivati di ergoline-2-tioeteri e loro solfossidi
GB2056437A (en) * 1979-08-07 1981-03-18 Erba Farmitalia Secoergoline derivatives
US4382940A (en) * 1979-12-06 1983-05-10 Farmitalia Carlo Erba S.P.A. Ercoline derivatives and therapeutic compositions having CNS affecting activity
DE3403067A1 (de) * 1984-01-30 1985-08-14 Eckart Prof. Dr. 6500 Mainz Eich Ergolin-derivate, verfahren zu ihrer herstellung, sie enthaltende arzneimittel und deren verwendung
IT1213206B (it) * 1984-08-07 1989-12-14 Inverni Della Beffa Spa Procedimento per la preparazione di derivati del lisergolo.
GB8612366D0 (en) * 1986-05-21 1986-06-25 Erba Farmitalia Ergoline esters
AU7914587A (en) * 1987-08-24 1989-03-31 Molecular Control Corporation Liquid crystal micelles, display, having concentric spheres

Also Published As

Publication number Publication date
JPH0745498B2 (ja) 1995-05-17
JPS6322577A (ja) 1988-01-30
IL82946A0 (en) 1987-12-20
DK322587D0 (da) 1987-06-24
DK322587A (da) 1987-12-26
FI872752A0 (fi) 1987-06-22
US5079364A (en) 1992-01-07
ZA874569B (en) 1988-02-24
PT85152A (en) 1987-07-01
SU1547708A3 (ru) 1990-02-28
EP0251652A2 (en) 1988-01-07
EP0251652A3 (en) 1989-04-05
FI85702C (fi) 1992-05-25
IE871652L (en) 1987-12-25
PT85152B (pt) 1990-03-30
AU597672B2 (en) 1990-06-07
IE61319B1 (en) 1994-11-02
HUT44543A (en) 1988-03-28
KR880000429A (ko) 1988-03-25
DE3779190D1 (de) 1992-06-25
IL82946A (en) 1991-04-15
US4843073A (en) 1989-06-27
NZ220543A (en) 1989-06-28
GR3005115T3 (es) 1993-05-24
HU196201B (en) 1988-10-28
ATE76407T1 (de) 1992-06-15
FI872752A (fi) 1987-12-26
GB8615471D0 (en) 1986-07-30
AU7463287A (en) 1988-01-07
KR950008970B1 (ko) 1995-08-10
DK170099B1 (da) 1995-05-22
EP0251652B1 (en) 1992-05-20
FI85702B (fi) 1992-02-14
CA1339533C (en) 1997-11-11

Similar Documents

Publication Publication Date Title
US5151423B1 (en) Heterocyclic n-oxide derivatives of substituted benzo(5,6)cycloheptapyridines, compositions and methods of use
DK73193D0 (da) Substituerede 1-(4-piperidinyl)-2-(phenylethylpyridinyl)-methanoner
MX173308B (es) Procedimiento para la preparacion de indolinas 3,3-disustuidas
DE3750443D1 (de) Cephalosporinverbindungen, Verfahren zu ihrer Herstellung und antibakterielle Mittel.
GR3020848T3 (en) 1,8-Naphthyridin-2-one derivatives
DE3785878D1 (de) 3,4-disubstituierte-2-azetidinon-derivate und verfahren zu ihrer herstellung.
ES2042567T3 (es) Un procedimiento para la preparacion de un derivado de ergolina.
PT85866A (en) Process for the preparation of therapeutic agents for the treatment of peptic ulcers containing 1,2,3,6-tetrahydro-3-methyl-1-(5-oxohexyl)-7-propyl-purine,6-dione and their derivatives
PT84205A (en) Process for preparing novel derivatives of erythromycylamine
ES2033256T3 (es) Procedimiento para preparar derivados fluorados de la vitamina d3.
YU135887A (en) Process for obtaining new tetracyclic derivatives of indole
GR3006108T3 (es)
DE69127238D1 (de) Verfahren zur Herstellung von Pyrido[1,2-a]pyrimidinderivaten
DK0686641T3 (da) 2'-Deoxy-5-fluoruridinderivat, farmaceutisk acceptabelt salt deraf, fremgangsmåde til fremstilling deraf, og antitumorlægem
TH13390EX (th) อนุพันธ์ของอินโดลและอินดาโซลสำหรับใช้รักษาและ ป้องกันผิดปกติเกี่ยวกับสมองใหญ่, การเตรียมและ การใช้สารเหล่านั้น
NO914201L (no) Fremgangsmaate ved fremstilling av 4 (1h) quinolonderivater

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 251652

Country of ref document: ES